1. Market Research
  2. > Pharmaceutical Market Trends
  3. > South Korea Pharmaceuticals and Healthcare Report Q3 2016

South Korea Pharmaceuticals and Healthcare Report Q3 2016

  • September 2016
  • -
  • Business Monitor International
  • -
  • 109 pages

Includes 3 FREE quarterly updates

BMI View: Policies in support of the local pharmaceutical sector in South Korea will be forthcoming. Thesector has the potential to serve as an alternative to electronic exports in driving economic growth, whichhas been facing headwinds. Government support at this juncture will also play a critical role as local firmsexpand internationally and maintain South Korea's competitiveness vis-à-vis other biomedical hubs such asSingapore, Taiwan and Japan.Headline Expenditure ProjectionsPharmaceuticals: KRW17,117.1bn (USD15.1bn) in 2015 to KRW17,666.6bn (USD14.7bn) in 2016;+3.2% in local currency terms and -2.7% in US dollar terms. Forecast broadly unchanged from previousquarter.Healthcare: KRW116,599.4bn (USD103.1bn) in 2015 to KRW124,224.3bn (USD103.5bn) in 2016; +6.5%in local currency terms and 0.4% in US dollar terms. Forecast upgraded from previous quarter.

Table Of Contents

South Korea Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (South Korea 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (South Korea 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (South Korea 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (South Korea 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (South Korea 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (South Korea 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (South Korea 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (South Korea 2012-2020) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (South Korea 2012-2020) 25
Pharmaceutical Trade Forecast 26
Structural Trends 26
Table: Pharmaceutical Trade Data And Forecasts (South Korea 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (South Korea 2014-2020) 28
Industry Risk Reward Index 29
Asia Pacific Risk/Reward Index - Q3 2016 29
South Korea Risk/Reward Index 35
Rewards 35
Risks 35
Regulatory Review 37
Intellectual Property Issues 37
Pricing And Reimbursement Regime 38
Table: Different Price Control Levers 39
Market Overview 44
Healthcare Sector 44
Table: Healthcare Resources (South Korea 2010-2015) 45
Table: Healthcare Personnel (South Korea 2010-2015) 45
Table: Healthcare Activity (South Korea 2010-2015) 46
Research And Development 49
Clinical Trials 51
Epidemiology 53
Competitive Landscape 56
Research-Based Industry 56
Generic Drugmakers 57
Table: Multinational Market Activity 59
Pharmaceutical Distribution 60
Pharmaceutical Retail Sector 61
Table: Pharmaceutical Retailers, 2000-10 62
Table: Timeline Of Slow OTC Liberalisation 63
Company Profile 64
Daewoong Pharmaceutical 64
Dong-A Pharmaceutical 67
Eli Lilly 71
GlaxoSmithKline 74
Hanmi Pharmaceutical Co 77
Merck and Co 81
Novartis 84
Pfizer 88
Sanofi 91
Yuhan Corporation 94
Demographic Forecast 98
Demographic Outlook 98
Table: Population Headline Indicators (South Korea 1990-2025) 99
Table: Key Population Ratios (South Korea 1990-2025) 99
Table: Urban/Rural Population and Life Expectancy (South Korea 1990-2025) 100
Table: Population By Age Group (South Korea 1990-2025) 100
Table: Population By Age Group % (South Korea 1990-2025) 101
Glossary 103
Methodology 105
Pharmaceutical Expenditure Forecast Model 105
Healthcare Expenditure Forecast Model 105
Notes On Methodology 106
Risk/Reward Index Methodology 107
Index Overview 108
Table: Pharmaceutical Risk/Reward Index Indicators 108
Indicator Weightings 109

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.